Integra LifeSciences Holdings Corp (IART)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Integra LifeSciences Holdings Corp (IART) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011736
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp (IART) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Integra LifeSciences Holdings Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Integra LifeSciences Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Integra LifeSciences Holdings Corp, Medical Equipment, Deal Details 12
Asset Purchase 12
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 12
Integra LifeSciences Acquires Ankle and Toe Replacement Products from Tornier for USD6 Million 14
Integra LifeSciences Acquires Ankle Replacement and Silastic Toe Replacement Products from Tornier 15
Integra LifeSciences Acquires Foot and Ankle Product Portfolio from Metasurg 16
Integra LifeSciences Acquires Medtronic MicroFrance and Certain Assets from Medtronic 17
Integra LifeSciences Completes Acquisition Of Confluent Surgical Product Line From Covidien For US$265 Million 19
Partnerships 20
Integra LifeSciences Holdings Enters Into Licensing Agreement With Stout Medical 20
Dr. Reddy’s Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 21
Integra LifeSciences Enters into Agreement with AlloSource 22
Integra LifeSciences Enters into Agreement with Vomaris Wound Care 23
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 24
Medistim Enters Into Distribution Agreement With Integra LifeSciences 25
Equity Offering 26
Integra LifeSciences Raises USD220 Million in Public Offering of Shares 26
Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 27
SeaSpine Spin Off from Integra LifeSciences 29
Integra LifeSciences Completes Public Offering Of Shares For US$161 Million 30
Debt Offering 32
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For US$230 Million 32
Asset Transactions 34
Natus Medical Acquires Neurosurgery Assets from Integra LifeSciences for USD47.5 Million 34
Acquisition 35
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 35
Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million 37
Integra LifeSciences Acquires Ascension Orthopedics For US$65 Million 38
Integra LifeSciences Acquires SeaSpine 39
Integra LifeSciences Holdings Corp – Key Competitors 40
Integra LifeSciences Holdings Corp – Key Employees 41
Integra LifeSciences Holdings Corp – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 46
Financial Announcements 46
Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results 46
Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 48
Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 50
Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 52
Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 54
Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 55
Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results 57
Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 58
Corporate Communications 60
Dec 05, 2016: Integra LifeSciences announces management changes 60
Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 61
Product News 62
Jun 15, 2017: Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 – 16, 2017 in Berlin, Germany 62
Jun 16, 2016: Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 – 17, 2016 in Lisbon, Portugal 63
Other Significant Developments 64
Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico 64
May 23, 2017: Integrum’s first delivery to Ottobock in the United States 65
Feb 25, 2016: Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health 66
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67

List of Tables
Integra LifeSciences Holdings Corp, Medical Equipment, Key Facts, 2016 2
Integra LifeSciences Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Integra LifeSciences Holdings Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Integra LifeSciences Holdings Corp, Deals By Market, 2011 to YTD 2017 9
Integra LifeSciences Holdings Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 12
Integra LifeSciences Acquires Ankle and Toe Replacement Products from Tornier for USD6 Million 14
Integra LifeSciences Acquires Ankle Replacement and Silastic Toe Replacement Products from Tornier 15
Integra LifeSciences Acquires Foot and Ankle Product Portfolio from Metasurg 16
Integra LifeSciences Acquires Medtronic MicroFrance and Certain Assets from Medtronic 17
Integra LifeSciences Completes Acquisition Of Confluent Surgical Product Line From Covidien For US$265 Million 19
Integra LifeSciences Holdings Enters Into Licensing Agreement With Stout Medical 20
Dr. Reddy’s Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 21
Integra LifeSciences Enters into Agreement with AlloSource 22
Integra LifeSciences Enters into Agreement with Vomaris Wound Care 23
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 24
Medistim Enters Into Distribution Agreement With Integra LifeSciences 25
Integra LifeSciences Raises USD220 Million in Public Offering of Shares 26
Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 27
SeaSpine Spin Off from Integra LifeSciences 29
Integra LifeSciences Completes Public Offering Of Shares For US$161 Million 30
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For US$230 Million 32
Natus Medical Acquires Neurosurgery Assets from Integra LifeSciences for USD47.5 Million 34
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 35
Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million 37
Integra LifeSciences Acquires Ascension Orthopedics For US$65 Million 38
Integra LifeSciences Acquires SeaSpine 39
Integra LifeSciences Holdings Corp, Key Competitors 40
Integra LifeSciences Holdings Corp, Key Employees 41
Integra LifeSciences Holdings Corp, Other Locations 42
Integra LifeSciences Holdings Corp, Subsidiaries 42

★海外企業調査レポート[Integra LifeSciences Holdings Corp (IART)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Imagineer Co., Ltd. (4644):企業財務及び戦略的SWOT分析
    Summary Imagineer Co., Ltd. (Imagineer) is a technology company that offers software products. The company designs, develops and markets gaming software and computer peripherals. The company’s products include mobile commerce, package software and education software. It offers services such as consu …
  • Onxeo SA (ONXEO):企業財務及び戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a bio-pharmaceutical company that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company’s pipeline products include Livatag, BelCHOP, Beleodaq, AMEP, AsiDNA, Validive and others. It provides treatment of liver cancer, treat …
  • International Consolidated Companies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' International Consolidated Comp …
  • Valenta Farmatsevtika (SHVZ):企業の財務及び戦略的SWOT分析
    Summary Valenta Farmatsevtika (Valenta), formerly Schelkovskii vitaminnyi zavod, is a pharmaceutical company that develops and manufactures innovative medicines for healthcare industry. It develops antibacterial, neurological, cardiological, antihistamine and parenteral feeding products. The company …
  • Golden Dawn Minerals Inc. (GOM):企業の財務及び戦略的SWOT分析
    Summary Golden Dawn Minerals Inc. (Golden Dawn) is a mineral company that offers exploration services. The company acquires, explores and develops uranium, silver, gold, iron and base metal properties. It holds interests in the Greenwood project including three contiguous properties located in the G …
  • Elron Electronic Industries Ltd. (ELRNF):企業概要、財務及び戦略的SWOT分析
    Summary Elron Electronic Industries Ltd. (Elron) is a healthcare technology company. The company provides technology services in medical devices and other technology fields. It develops remote patient monitoring solution for congestive heart failure patients. The company develops automatic implantab …
  • Curtiss-Wright Corp (CW):石油・ガス:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • Intelligent Energy, Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Intelligent Energy, Ltd. (Intelligent Energy), a subsidiary of Intelligent Energy Holdings PLC is a power technology company that offers fuel systems. The company develops modular and low carbon fuel cell systems. Its products include air-cooled fuel cell systems and evaporatively cooled fue …
  • Refocus Group Inc:製品パイプライン分析
    Summary Refocus Group Inc (Refocus Group) is a medical equipment company that concentrates on research and development of treatments for human vision disorders. The company has developed visability implant system (VIS) for the treatment of presbyopia. Its VIS procedure is an outpatient procedure tha …
  • Verisante Technology Inc (VRS):製品パイプライン分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • Genworth MI Canada Inc.:企業の戦略・SWOT・財務分析
    SummaryGenworth MI Canada Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • UniCredit S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' UniCredit S.p.A. Mergers and Ac …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • BMG Resources Limited (BMG):企業の財務及び戦略的SWOT分析
    Summary BMG Resources Limited (BMG) formerly Brazilian Metals Group Limited is an energy company that offers exploration services. The company explores portfolio of exploration tenements in the Republic of Cyprus. It offers products such as nickel, copper, gold and cobalt. BMG operates with copper-g …
  • German Cancer Research Center:企業のM&A・提携動向(医療機器分野)
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s services include skin protection plans in detail and monitoring, addiction and alcohol services, general medical examinations, intervention in …
  • Sirtris Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sirtris Pharmaceuticals, Inc. M …
  • JSC “RAO Energy System of East”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC "RAO Energy System of East" …
  • Fresenius Kabi AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fresenius Kabi AG Mergers and A …
  • Hunter Engineering Co:企業の戦略的SWOT分析
    Hunter Engineering Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆